Danny is an analytics platform which is able to evaluate massive amounts of real-world data from multiple sources in the oncology and cardiology fields.
Danny provides comprehensive searches, in-depth analyses, predictions and treatment solutions to physicians, researchers and payers.
The platform is powered by SAP HANA – the world’s leading database platform.
Danny Platform’s homepage offers fast access to these main applications – Danny Analytics and Danny Predictions.
Danny’s Launchpad Home Page offers fast access to these main applications
The application provides physicians with immediate summary of healthcare data – in aggregate or of individual patients – for delivery of high-quality cost-effective care. Danny Analytics provides statistical data, benchmarks and real-world evidence of therapeutics. Predictive analytics evaluates based on retrospective data for extrapolation of clinically important endpoints
Danny enables better tracking and evaluation of real-world data to uncover newly approved drug adaptation patterns, market access, and drug effectiveness. Cost-benefit analyses and economic evaluations using accepted models with real-world evidence for survival extrapolations and ICER calculations, in support of HTA submissions
Due to rising costs of therapeutics, there is an urgent need to move away from fee-for-service toward performance-based care. As such, evaluating effectiveness of drugs and comparators based on clinical and real-world evidence are critically important. Danny provides pharmacoeconomic models to evaluate and extrapolate survival and costs based on clinical and local data for cost-effectiveness analyses. This gives budgetary predictability and assessment of effectiveness within public budget spending
Danny Analytics provides real-time access to patients eligibility for clinical trials of interest. Using pre-defined inclusion and exclusion criteria, eligible patients are automatically updated for improved efficiency and reduced costs in patient recruitment
It has the full potential to provide the necessary tools for real-time assessment of the benefits and effects of newly approved drugs. This will ensure the use of effective therapies for patients, which is of key importance for the future development of healthcare in our country
It enables us to make conclusions based on large amount of important information when deciding on the appropriate therapy for patients. Danny Analytics give us access to specific parameters such as five-year overall survival, progression-free survival, etc. All this is of the utmost importance for the fate of our patients - especially when we need to make the best decision quickly.
It encompasses large time periods and reports on the patient's condition and the results of therapies for long-term observation and continuous follow-ups. This type of application would also expedite the use of medical devices in healthcare technology assessments (HTAs) for areas where they still have not be used.
Experience Danny and its benefits for your organization.Request a Demo